绒毛膜下血肿与早产风险:系统综述与Meta分析
该系统综述与Meta分析纳入16项研究,评估早孕绒毛膜下血肿与单胎妊娠早产及其他不良妊娠结局的关联。结果显示早孕绒毛膜下血肿与早产无显著关联(OR 1.11;95%CI 0.82-1.51),但与流产相关(自然妊娠OR 3.07;95%CI 1.98-4.75;辅助生殖妊娠OR 1.45;95%CI 1.1-1.90)。
要点
- 早孕绒毛膜下血肿与单胎妊娠早产无显著关联(OR 1.11;95%CI 0.82-1.51)。
- 早孕绒毛膜下血肿与自然妊娠流产相关(OR 3.07;95%CI 1.98-4.75)。
- 早孕绒毛膜下血肿与辅助生殖妊娠流产相关(OR 1.45;95%CI 1.1-1.90)。
核心结论
- 在单胎妊娠中,早孕绒毛膜下血肿与早产无关联,虽与流产相关但未说明流产的可能孕周,需更多研究进一步解决所提出的研究问题。
研究设计与样本
- 系统综述与Meta分析,检索2000年至2022年7月15日发表的英文研究,纳入16项研究(自然妊娠12项、辅助生殖妊娠4项),分析早孕绒毛膜下血肿与围产结局的关联。
主要发现
- 早孕绒毛膜下血肿与单胎妊娠早产无显著关联(OR 1.11;95%CI 0.82-1.51),与其他不良结局亦无显著关联。
- 早孕绒毛膜下血肿与单胎妊娠流产相关:自然妊娠OR 3.07(95%CI 1.98-4.75),辅助生殖妊娠OR 1.45(95%CI 1.1-1.90)。
- 回归分析发现纳入研究的大异质性可能与纳入人群(早孕绒毛膜下血肿)是否合并先兆流产有关(P<.05)。
- 敏感性分析未发现导致大异质性的单项研究。
- 15项与早产相关的研究无发表偏倚(Egger检验:P=.26)。
关键数值与推荐
- 纳入标准:单胎妊娠、绒毛膜下血肿、围产结局;排除多胎妊娠、基础分子研究、病例报告(系列)和会议综述。
- 主要结局为早产;次要结局为流产、胎儿生长受限、剖宫产和子痫前期。
- 方法学质量采用Cochrane风险评估量表评价,数据分析主要使用Review Manager(RevMan)和Stata,结果以OR和95%CI表示。
临床怎么用
- 原文未据此给出推荐。
局限性
- 纳入研究存在大异质性,可能与纳入人群是否合并先兆流产有关(P<.05)。
- 未说明流产的可能孕周。
- 需更多研究进一步解决所提出的研究问题。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: This study aimed to investigate the association between early pregnancy with subchorionic hematoma and preterm delivery and other adverse pregnancy outcomes in singleton pregnancies. DATA SOURCES: English studies published from 2000 to July 15, 2022 were retrieved from PubMed, Web of Science, and the Cochrane Library. STUDY ELIGIBILITY CRITERIA: The inclusion criteria were: singleton pregnancy, subchorionic hematoma, and perinatal outcomes. Studies including multiple pregnancy, basic molecular studies, case reports (series), and conference reviews were excluded. METHODS: Data analysis was mainly conducted with Review Manager (RevMan) and Stata, and the results were represented with odds ratios and 95% confidence intervals. The methodological quality of the included studies was evaluated by the Cochrane risk assessment scale. RESULTS: In total, 370 studies were retrieved from the above databases. Our review included 16 studies and divided them into 2 subgroups: natural pregnancy (12 studies) and assisted reproductive pregnancy (4 studies). The relevant characteristics of each study were analyzed in detail. The primary outcome was preterm delivery. The secondary outcomes were miscarriage, fetal growth restriction, cesarean delivery, and preeclampsia. We found that subchorionic hematoma in the first trimester was not significantly associated with preterm delivery (odds ratio, 1.11; 95% confidence interval, 0.82-1.51) or other adverse outcomes in singleton pregnancy. Regression analysis found that the large heterogeneity of the included studies might be related to whether the included study population (early pregnancy with subchorionic hematoma) was complicated with threatened abortion (P<.05). However, no studies caused large heterogeneity according to sensitivity analysis. Finally, 15 studies related to preterm delivery did not have publication bias (Egger test: P=.26). However, subchorionic hematoma in the first trimester was associated with miscarriage in single pregnancies (natural pregnancy: odds ratio, 3.07; 95% confidence interval, 1.98-4.75; assisted reproductive pregnancy: odds ratio, 1.45; 95% confidence interval, 1.1-1.90). CONCLUSION: In singleton pregnancy, we found no association between subchorionic hematoma in the first trimester and preterm delivery. Although there was a correlation with miscarriage, the possible gestational age of miscarriage was not stated. More studies are needed to further address the herein posed research questions.
引用
- Yan X, Xu H, Li J, et al. Subchorionic hematoma and risk of preterm delivery: a systematic review and meta-analysis. Am J Obstet Gynecol MFM. 2022. PMID: 36328350. doi:10.1016/j.ajogmf.2022.100791
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。